Protection of rabbit retina from ischemic injury by flupirtine

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 2, 1996, Pages 274-280

  Osborne, N N ^a   Schwarz, M ^b   Pergande, G ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c ASTA MEDICA AG   (Germany)

Author keywords

flupirtine; protection; rabbit; retinal ischemia

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE TRIPHOSPHATE; FLUPIRTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ELECTRORETINOGRAPHY; IMMUNOCOMPETENT CELL; INTRAOCULAR PRESSURE ABNORMALITY; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; RETINA ISCHEMIA;

ADENOSINE TRIPHOSPHATE; AMINOPYRIDINES; ANALGESICS; ANIMALS; ELECTRORETINOGRAPHY; GAMMA-AMINOBUTYRIC ACID; IMMUNOHISTOCHEMISTRY; ISCHEMIA; NEUROPROTECTIVE AGENTS; RABBITS; RATS; REPERFUSION; REPERFUSION INJURY; RETINA; RETINAL DISEASES; RETINAL VESSELS; SEROTONIN;

EID: 0030041052     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic ischemic death. Am Rev Neurosci. 1990;13:171-182.
2. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic/ischemic brain damage. Ann Neurol. 1986;19:105-111.
3. Siesjö BK. Pathophysiology and treatment of focal cerebral ischemia: II: Mechanisms of damage and treatment. J Neurosurg. 1992;77:337-354.
4. Olney JW. Excitotoxic amino acids and neuropsychiatric disorders. Ann Rev Pharmacol. 1990;30:47-71.
5. Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. In: Lodge D, Collingridge G, eds. The Pharmacology of Excitatory Amino Acids. Cambridge: Elsevier; 1991;54-62.
6. Hara H, Sukamoto T, Kogure K. Mechanism and pathogenesis of ischemia-induced, neuronal damage. Prog Neurobiol. 1993;40:645-670.
7. McBain CJ, Mayer ML. N-methyl-D-aspartate acid receptor structure and function. Physiol Rev. 1994; 74:723-759.
8. Rosenmund C, Westbrook GL. Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron. 1993;10:805-814.
9. Friedel HA, Fitton A. Flupirtine: A review of its pharmacological properties and therapeutic efficacy in pain states. Drugs. 1993;45:548-569.
10. Bleyer H, Carlsson KH, Erkel HJ. Jurna I. Flupirtine nociceptive activity evoked in rat thalamus. Eur J Pharmacol. 1988;151:259-265.
11. Schwarz M, Block F, Pergande G. N-methyl-D-aspartate (NMDA) mediated muscle relaxant action of flupirtine in rats. Neuroreport. 1994;5:1981-1984.
12. Osborne NN, Pergande G, Block F, Schwarz M. Immunohistochemical evidence for flupirtine acting as an antagonist on the N-methyl-D-aspartate and homocysteine acid-induced release of GABA in the rabbit retina. Brain Res. 1994a;667:291-294.
13. Perovic S, Schleger C, Pergande G, Iskric S, Ushijima H, Rytik P, Müller WEG. The triaminopyridine flupirtine prevents cell death in rat cortical cell-induced by N-methyl-D-aspartate and gp120 of HIV-1. Eur J Pharmacol. 1994;288:27-33.
14. Louzada-Junior P, Dias JJ, Santos WF, Lachat HF, Coutinho-Netto J. Glutamate release in experimental ischaemia of the retina: An approach using microdialysis. J Neurochem. 1992;59:358-363.
15. Gupta LY, Marmor MF. Mannitol, dextromethorphan and catalase minimize ischemic damage to retinal pigment epithelium and retina. Arch Ophthalmol. 1993;111:384-388.
16. Yoon TH, Marmor MF. Dextromethorphan protects retina against ischemic injury in vivo. Arch Ophthalmol. 1989;107:409-411.
17. Cao W, Zaharia M, Drumheller A, et al. Effects of dextromethorphan on ischemia induced electroretinogram changes in rabbit. Curr Eye Res. 1994;13:97-102.
18. Block F, Pergande G, Schwarz M. Flupirtine protects against ischaemic retinal dysfunction in rats. Neuroreport. 1994;5:2630-2632.
19. Barnett N, Osborne NN. Prolonged bilateral carotid artery occlusion induces electrophysiological and immunohistochemical changes to rat retinal without causing histological damage. Exp Eye Res. 1995;61:83-90.
20. Galin MA, Baras I, Cavero R. Ophthalmodynamometry using suction. Arch Ophthalmol 1969;81:494-501.
21. Osborne NN, Patel S, Beaton DW, Neuhoff V. GABA neurons in retinas of different species and their postnatal development in situ and in culture in the rabbit retina. Cell Tiss Res. 1986;243:117-123.
22. Harris DA. Spectrophotometric assays. In: Harris DA, Bashford CL, eds. Spectrophotometry and Spectrofluorimetery: A Practical Guide. Oxford: IRL Press; 1989;47-90.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein and dye binding. Anal Biochem. 1976;72:248-254.
24. Osborne NN, Block F, Sontag K. Reduction of ocular blood flow results in glial fibrillary acid protein (GFAP) expression in retinal Müller cells. Vis Neurosci. 1991;7:637-639.
25. Osborne NN, Herrera AJ. The effect of experimental ischaemia and excitatory amino acid agonists on the GABA and serotonin immunoreactivities in rabbit retina. Neuroscience. 1994;59:1071-1081.
26. Osborne NN, Wood J, Müller A. The influence of experimental ischaemia on protein kinase C and the GABAergic system in the rabbit retina. Neuropharmacology. 1995;34:1279-1288.
27. Scatton B. The NMDA receptor complex. Fundam Clin Pharmacol. 1993;7:389-400.
28. Aizeriman E, Lipton SA, Loring RH. Selective modulation of NMDA responses by reduction and oxidation. Neuron. 1989;2:1257-1263.
29. Osborne NN. In vitro experiments on the metabolism, uptake and release of 5-hydroxytryptamine in bovine retina. Brain Res. 1980;184:283-297.